Why the study?
Does metabolic syndrome impact ablation outcomes in patients with atrial fibrillation?
Does metabolic syndrome impact ablation outcomes in patients with atrial fibrillation?
This systematic review evaluates the impact of metabolic syndrome and lifestyle modifications on the success rate of atrial fibrillation ablation.
Metabolic syndrome warrants pre-ablation assessment in AF patients; extends evidence on lifestyle modifications to improve procedural success.
Metabolic syndrome (MS), a pro-inflammatory state with hypertension, diabetes, dyslipidemia and obesity is presumed to be a close associate of atrial fibrillation (AF). However, the exact mechanism by which MS facilitates perpetuation of AF is yet to be fully understood. Moreover, the impact of the components of MS as well as MS as a group, on ablation-outcome in AF is not clearly elucidated until now. This review has compiled the results from major studies that have looked into those risk factors and defined their significance in influencing ablation-outcome in AF. It has also overviewed the impact of life-style changes that might improve the success rate of AF-ablation by effectively addressing the different constituents of MS.
No takes yet. Share an insight, caveat, or question.
Mohanty et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: